companydata.dkcompanydata.dk

SCANORTO A/S: Financial statements 2017

CVR: 12687648

Source: annual report 2017, Danish Business Authority

01/01/2017 – 31/12/2017

SCANORTO A/S (CVR 12687648) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 8,586,717 and a net result of DKK 264,498. Equity in the 2017 report amounted to DKK 4,121,610. The solvency ratio was 52.5%. The company had 11 employees in the financial year.

Gross Profit
DKK 8,586,717
Profit/Loss
DKK 264,498
Equity
DKK 4,121,610
Total Assets
DKK 7,851,985
Employees
11

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2017-8.6 mio.264 t.4.1 mio.11
2015-11.7 mio.-3.5 mio.2.6 mio.18
2014-13.9 mio.2.5 mio.8.1 mio.17
2013-14.7 mio.4 mio.7.6 mio.15

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on SCANORTO A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2017

SCANORTO A/S publishes interim reportJun 23, 2017

SCANORTO A/S has published its interim report for the period July 1, 2015 – December 31, 2016.

About SCANORTO A/S

SCANORTO A/S is a Danish company of the type Aktieselskab based in Kgs. Lyngby, founded in 1989. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named LASSE LAGER HOLDING ApS and ASX 14746 ApS. The management consists of Karel Rajchert. The board consists of Karel Budka (chair), Filipa Alexandra Pinto De Almeida and Karel Rajchert. The company is owned by NOBEL BIOCARE DANMARK A/S. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 12,395,453 and a net result of DKK 1,917,702 compared with DKK 1,654,974 the year before. Equity in the 2025 report amounted to DKK 12,950,705.

Source: annual report 2025, Danish Business Authority